Federal Register / Vol. 87, No. 45 / Tuesday, March 8, 2022 / Notices 12965 

regional hospitals. The award will 

improve support to and the 

coordination of the TB and OIs 

laboratory network for quality assured 

diagnosis of TB/DR–TB, including 

smear microscopy (LED), 

Lipoarabinomannan Assay (LF–LAM) 

for the diagnosis and screening of active 

tuberculosis in people with HIV, solid 

and liquid culture, and molecular WHOrecommended diagnostic tests (LIPA, 

Xpert Ultra). Funding amounts for years 

2–5 will be set at continuation. 

DATES: The period for this award will be 

September 30, 2022 through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: 

Titania Techeira, Center for Global 

Health, Centers for Disease Control and 

Prevention, CDC Coˆte d’Ivoire, U.S. 

Embassy B.P. 730 Abidjan Cidex 03, 

Telephone: 800–232–6348, Email: iux2@

cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

single-source award will strengthen IPCI 

as the National Reference Laboratory for 

TB and microbiology tests. This will 

enable IPCI to better and further sustain 

the efforts in 27 Anti-Tuberculosis 

Centers (CATs) and in 16 regional 

reference laboratories previously 

supported for decentralized 

microbiology diagnosis. 

IPCI is in a unique position to 

conduct this work as it is the designated 

laboratory institution in charge of 

integrated Disease Surveillance and 

Response (IDSR) in Cote d’Ivoire by the 

Ministry of Health (MOH) and Ministry 

of Scientific Research. IPCI is 

responsible for the implementation, 

monitoring, and evaluation of 

population-based TB, malaria and 

epidemic disease surveillance, 

including HIV opportunistic infections, 

as well as prevention and care policies 

and interventions. 

Summary of the Award 

Recipient: IPCI. 

Purpose of the Award: The purpose of 

this award is to sustain decentralization 

of HIV-associated microbiology at 

regional hospitals and to expand 

interventions to additional regional 

hospitals. It will improve support to and 

the coordination of the TB and OIs 

laboratory network for quality assured 

diagnosis of TB/DR–TB, including 

smear microscopy (LED), 

Lipoarabinomannan Assay (LF–LAM) 

for the diagnosis and screening of active 

tuberculosis in people with HIV, solid 

and liquid culture, and molecular WHOrecommended diagnostic tests (LIPA, 

Xpert Ultra). 

Amount of Award: The approximate 

year 1 funding amount will be 

$1,000,000 in Federal Fiscal Year (FYY) 

2022 funds, subject to the availability of 

funds. Funding amounts for years 2–5 

will be set at continuation. 

Authority: Public Law 108–25 (the 

United States Leadership Against HIV 

AIDS, Tuberculosis and Malaria Act of 

2003). 

Period of Performance: September 30, 

2022 through September 29, 2027. 

Dated: March 2, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–04790 Filed 3–7–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund 

Machakos County Government, 

Makueni County Government, Kitui 

County Government, and Nairobi 

County Government (Represented by 

Nairobi Metropolitan Services), Kenya 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS) announces the 

award of approximately $1,400,000 for 

Year 1 of, and an average 1 year award 

amount of $350,000, funding to the 

Machakos County Government, 

Makueni County Government, Kitui 

County Government, and Nairobi 

County Government (represented by 

Nairobi Metropolitan Services). The 

awards will advance current efforts to 

attain ownership, leadership, and 

implementation capacity for HIV 

services by the Nairobi, Machakos, 

Makueni and Kitui County 

governments, and to achieve and sustain 

HIV epidemic control through 

sustainable high-quality comprehensive 

HIV prevention and treatment services. 

Funding amounts for years 2–5 will be 

set at continuation. 

DATES: The period for this award will be 

September 30, 2022 through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Lucy Nganga, Center for Global Health, 

Centers for Disease Control and 

Prevention, KEMRI Campus, Mbagathi 

Road—off Mbagathi Way, P.O. Box 606, 

Village Market, 00621, Nairobi, Kenya. 

Telephone: 800–232–6348, Email: 

hon5@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

single-source awards will support 

Nairobi, Machakos, Makueni and Kitui 

County Governments to achieve two 

goals: (1) Implementation and 

expansion of comprehensive HIV 

services with the goal of achieving and 

maintaining epidemic control, and (2) 

Strengthening the capacity of Nairobi, 

Machakos, Makueni and Kitui county 

governments’ Department of Health 

Services to progressively manage, 

sustain and transition to ownership of 

HIV service delivery. 

The 2010 Kenyan constitution 

(Chapter 11, article 174–176;189) 

https://www.klrc.go.ke/index.php/ 

constitution-of-kenya; the Fourth 

Schedule, Part 2 https://www.klrc.go.ke/ 

index.php/constitution-of-kenya/167- 

schedules-schedules/fourth-scheduledistribution-of-functions-betweennational-and-the-county-governments 

and the Kenya Health Act (Act No. 21 

2017) http://kenyalaw.org:8181/exist/ 

kenyalex/actview.xql?actid=

No.%2021%20of%202017 prescribed 

roles for the new county government, 

whereby each county is responsible for 

provision of health care services to its 

residents. Nairobi, Machakos, Makueni 

and Kitui County Governments’ 

Departments of Health Services have the 

sole mandate to manage and implement 

Nairobi, Machakos, Makueni and Kitui 

Counties’ public health response to HIV 

and implementing partners must work 

through these entities. CDC’s support to 

Nairobi, Machakos, Makueni and Kitui 

County will directly increase the 

capacity of Department of Health 

Services to support long-term 

sustainable HIV service delivery 

response in Kenya. 

Summary of the Award 

Recipient: Machakos County 

Government, Makueni County 

Government, Kitui County Government, 

and Nairobi County Government 

(represented by Nairobi Metropolitan 

Services). 

Purpose of the Award: The purpose of 

this award is to advance current efforts 

to attain ownership, leadership, and 

implementation capacity for HIV 

services by the Nairobi, Machakos, 

Makueni and Kitui County 

governments, and to achieve and sustain 

HIV epidemic control through 

sustainable high-quality comprehensive 

HIV prevention and treatment services. 

This will be achieved through health 

system strengthening and increased 

coverage of high quality, client-centered 

comprehensive HIV prevention and 

treatment services, resulting in a 


lotter on DSK11XQN23PROD with NOTICES1
12966 Federal Register / Vol. 87, No. 45 / Tuesday, March 8, 2022 / Notices 

decrease in HIV incidence and 

reduction in HIV associated morbidity 

and mortality. 

Amount of Award: The approximate 

year 1 funding amount in Federal Fiscal 

Year (FFY) 2022 funds will be, subject 

to the availability of funds: 

• Kitui County: Anticipated Year 1 

Funding Amount is $300,000. 

• Makueni County: Anticipated Year 

1 Funding Amount is $300,000. 

• Machakos County: Anticipated Year 

1 Funding Amount is $300,000. 

• Nairobi County: Anticipated Year 1 

Funding Amount is $500,000. 

Funding amounts for years 2–5 will 

be set at continuation. 

Authority: Public Law 108–25 (the 

United States Leadership Against HIV 

AIDS, Tuberculosis and Malaria Act of 

2003). 

Period of Performance: September 30, 

2022 through September 29, 2027. 

Dated: March 2, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–04824 Filed 3–7–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund 

Burkina Faso Ministry of Health 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $450,000 for 

Year 1 of funding to the Burkina Faso 

Ministry of Health. to build laboratory 

and SI capacity to improve the 

provision of HIV testing, treatment, 

retention in line with HIV epidemic 

control and 95–95–95 targets (95% of 

HIV-positive individuals knowing their 

status, 95% of those receiving ART 

[Antiretroviral therapy], and 95% of 

those achieving viral suppression). 

Funding amounts for years 2–5 will be 

set at continuation. 

DATES: The period for this award will be 

September 30, 2022, through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: 

Trong Ao, Center for Global Health, 

Centers for Disease Control and 

Prevention, CDC Ghana Office, U.S. 

Embassy, 24 Fourth Circular Road, 

Cantonments, Accra Ghana, Telephone: 

800–232–6348, Email: tfa8@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

single-source award will support the 

Burkina Faso Ministry of Health to 

implement HIV strategic information 

and laboratory strengthening activities 

in Burkina Faso. The National HIV/ 

AIDS control program is one of the 

specialized programs within the 

Ministry of Health. The Burkina Faso 

Ministry of Health is in a unique 

position to conduct this work, as it 

functions under the Directorate of 

Disease Prevention and control of the 

Ministry and is the mandated institution 

to provide HIV treatment clinical 

services and guidelines in Burkina Faso. 

Summary of the Award 

Recipient: Burkina Faso Ministry of 

Health. 

Purpose of the Award: The purpose of 

this award is to build laboratory and SI 

capacity to improve the provision of 

HIV testing, treatment, retention in line 

with HIV epidemic control and 95–95– 

95 targets. This award strives to build 

and strengthen laboratories that are 

equipped with the appropriate 

diagnostic technologies, trained and 

skilled staff, and systems that can 

provide efficient services. It will also 

strengthen SI systems, data quality 

assurance, and staff capacity responsible 

for managing facility-based, survey and 

surveillance data operating at national 

and subnational levels. 

Amount of Award: The approximate 

year 1 funding amount will be $450,000 

in Federal Fiscal Year (FYY) 2022 

funds, subject to the availability of 

funds. Funding amounts for years 2–5 

will be set at continuation. 

Authority: This program is authorized 

under Public Law 108–25 (the United 

States Leadership Against HIV AIDS, 

Tuberculosis and Malaria Act of 2003). 

Period of Performance: September 30, 

2022, through September 29, 2027. 

Dated: March 2, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–04814 Filed 3–7–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund the 

Southern Provincial Health Office 

(SPHO), Lusaka Provincial Health 

Office (LPHO), Western Provincial 

Health Office (WPHO), and Eastern 

Provincial Health Office (EPHO) in 

Zambia 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $57,500,000 for 

total year 1 of funding, and an average 

1-year award amount of $14,375,000, to 

the Southern Provincial Health Office 

(SPHO), Lusaka Provincial Health Office 

(LPHO), Western Provincial Health 

Office (WPHO), and Eastern Provincial 

Health Office (EPHO)in Zambia. The 

awards will provide the Provincial 

Health Offices (PHOs) with CDC 

technical assistance and financial 

support to maintain and sustain the 

provinces’ overall leadership and 

oversight for implementing high-impact 

HIV combination prevention, treatment 

and support services, including clinical, 

surveillance, and laboratory services as 

well as to identify and mitigate 

emerging disease threats for people 

living with HIV (PLHIV). Funding 

amounts for years 2–5 will be set at 

continuation. 

DATES: The period for this award will be 

September 30, 2022 through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: 

Carolina Granados, Center for Global 

Health, Centers for Disease Control and 

Prevention, 351 Independence Ave., 

Lusaka, Zambia, Telephone: 800–232– 

6348, Email: hsy7@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

single-source award will support the 

Zambian Ministry of Health to achieve 

and sustain gains made in HIV epidemic 

control in four Zambian Provinces, 

SPHO, LPHO, WPHO, EPHO. The PHOs 

will provide programmatic oversight, 

coordination, and direct service delivery 

in the provision of comprehensive HIV 

prevention, treatment, and support 

services, while strengthening health 

systems for sustainability. Broad areas 

of support include, but are not limited 

to: 


lotter on DSK11XQN23PROD with NOTICES1